Navigation Links
Quest Diagnostics Unveils Care360(TM) EHR
Date:3/1/2010

EHR adoption in the United States has been very low, largely driven by high costs and difficulties around usability. Though eighty percent of the nation's patient care is delivered in small practices, most EHR offerings do not address the needs of the small-practice physician. The features and functionality of Care360 were developed using feedback Quest Diagnostics gathered from hundreds of physicians across the United States. Care360 EHR was specifically designed with the needs of the small practice in mind. It helps physicians embrace technology without incurring large capital costs or practice disruptions, including such features as patient demographics, clinical notes, problem lists, medications, vital signs, past medical history, immunizations, laboratory data and radiology reports. Care360 EHR can generate a complete record of a clinical patient encounter, and automate and streamline the clinician's workflow.

To help the industry move forward in the absence of final meaningful use guidelines, Quest Diagnostics is offering all physicians a 90-day free trial period to adopt the Care360 EHR or ePrescribing solution. The company is committed that its Care360 EHR will fully comply with the EHR certification criteria once they are established under the American Recovery and Reinvestment Act (ARRA), and is offering special pre-certification pricing until government meaningful use standards have been set. Under the terms of the promotion, physicians have the opportunity to try either Care360 EHR or Care360 ePrescribing free for a 90-day period. At the conclusion of the 90-day trial period, subscription rates will apply.


'/>"/>
SOURCE Quest Diagnostics Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Quest Diagnostics Introduces ClariSure(TM) Test for Identifying Chromosome Abnormalities Associated With 85 Developmental Disorders in Children
2. VioQuest Pharmaceuticals Completes Enrollment of Phase I Trial of Lenocta(TM)
3. Two Point of Care Tests From Quest Diagnostics Receive FDA 510(k) Clearance
4. Video: Quest Diagnostics Health Trends(TM) Report Shows Significant Gap in Care for Patients With Chronic Kidney Disease
5. VioQuest Pharmaceuticals Announces Dosing of First Patient in Phase IIa Solid Tumor Study for Lenocta(TM), a Novel Protein Tyrosine Phosphatase Inhibitor
6. Centocor and Janssen-Cilag Submit Applications Requesting Approval of Ustekinumab in the U.S. and Europe for Treatment of Moderate to Severe Plaque Psoriasis
7. U.S. Patent Office Rejects Key HIV/AIDS Drug Patents at PUBPAT Request: Government Finds Prior Art Submitted By PUBPAT Invalidates All of Gilead Sciences Claims
8. Portrait(R) Plasma - A New Non-Surgical Option for one of the Most Requested Aesthetic Treatment - Aging Eyes
9. CSL Behring Submits BLA Requesting Approval of C1-Esterase Inhibitor for the Treatment of Hereditary Angioedema
10. BRAVE-3 Questions Value of Abciximab in PCI for Heart Attack
11. ImQuest Publishes Results of Important Structure Activity Relationship Program on Dual Acting Pyrimidinediones
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2015)... NASHVILLE, Tenn. , April 30, 2015  Cumberland ... it will release first quarter 2015 financial results after ... conference call and live Internet webcast will be held ... Time to discuss the results. To participate ... or 253-237-1032 (for international callers).  A rebroadcast of the ...
(Date:4/30/2015)... 2015  Nektar Therapeutics (Nasdaq: NKTR ) today ... March 31, 2015. Cash and investments ... million as compared to $262.8 million at December 31, ... March 31, 2015 includes a $100.0 million milestone payment ... commercial sale of Movantik™(naloxegol) in the U.S. ...
(Date:4/30/2015)... plc (NYSE: PRGO ; TASE) today announced that Perrigo Chairman, ... the 2015 Deutsche Bank 40 th Annual Healthcare Conference at ... in Boston , MA.  The ... C. Papa will present at the Bank of America Merrill ... 2015 at the Encore at Wynn Las Vegas Hotel in ...
Breaking Medicine Technology:Cumberland Pharmaceuticals To Announce First Quarter 2015 Financial Results 2Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 2Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 3Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 4Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 5Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 6Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 7Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 8Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 9Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 10Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 11Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 12Perrigo Company To Present At Upcoming Healthcare Conferences 2Perrigo Company To Present At Upcoming Healthcare Conferences 3
... Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) today announced that ... New Drugs ("OND") in Maryland and presented its arguments supporting ... Drug Application ("NDA") 22-481 support the conclusion that pixantrone is ... consideration of our appeal.  While we understand disputes of this ...
... SQNM ), today announced the awards of non-qualified ... common stock for six new employees under the company,s New ... Of these shares, 14,450 have an exercise price ... Sequenom,s common stock on February 28, and 60,000 have a ...
Cached Medicine Technology:FDA's Office of New Drugs Meets With Cell Therapeutics on its Appeal on Pixantrone 2FDA's Office of New Drugs Meets With Cell Therapeutics on its Appeal on Pixantrone 3Sequenom Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 2Sequenom Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 3
(Date:5/2/2015)... Ohio (PRWEB) May 02, 2015 On ... Liverpool City Hospital (ELCH) gathered to celebrate improvements in ... River Valley Health Partners (RVHP), had zero acquired ventilator ... urinary catheter associated infections. ELCH was also recently named ... The management team at ELCH credited the teamwork of ...
(Date:5/1/2015)... Frisco, Texas (PRWEB) May 02, 2015 ... Frisco, Texas, is proud to announce the addition of ... Jen Widerstrom is a life long athlete, growing up ... fitness passion after college by becoming a personal trainer ... since been the face of several TV shows highlighting ...
(Date:5/1/2015)... Va. (PRWEB) May 01, 2015 The ... nation’s leading nonprofit authority on the use of health ... as a key contributing resource to the United States ... use of electronically readable cards in Medicare. The report, ... and Providers ” was released to the public on ...
(Date:5/1/2015)... Linda, CA (PRWEB) May 01, 2015 ... our genetic makeup and the interplay of genes with ... up with developments can be daunting. , LabRoots, the ... and clinical diagnostics professionals, will soon host its annual ... , At BioConference Live Genetics and Genomics 2015 ...
(Date:5/1/2015)... May 01, 2015 The frozen yogurt ... the Hickory Crawdads (NC) and the Myrtle Beach Pellicans ... in-stadium concession locations and offer fans discounts at local ... the Hickory Community,” said Luke Shook, co-owner of the ... opportunity and we look forward to enjoying the games ...
Breaking Medicine News(10 mins):Health News:East Liverpool City Hospital Celebrates Patient Care Improvements 2Health News:IDLife LLC Announces New Partnership with Fitness Celebrity, Jen Widerstrom 2Health News:WEDI Contributes to Newly Released U.S. Government Accountability Office (GAO) Study on Potential Use of Electronically Readable Medicare Cards 2Health News:WEDI Contributes to Newly Released U.S. Government Accountability Office (GAO) Study on Potential Use of Electronically Readable Medicare Cards 3Health News:Recent Advances in Genetics and Genomics: A BioConference Live 2015 Virtual Event 2Health News:Recent Advances in Genetics and Genomics: A BioConference Live 2015 Virtual Event 3Health News:sweetFrog Announces Minor League Baseball Partnerships 2
... cancer treatment, chemobrain a range of symptoms including ... subtle cognitive changes following chemotherapy seriously diminishes women,s ... they have to adopt a range of coping strategies ... Breast cancer survivors tell their story in a ...
... , SAN DIEGO, Sept. 17 ... that the company,s first laboratory developed test, the SensiGene(TM) Cystic ... is available exclusively through the Sequenom Center for Molecular Medicine, ... laboratory and a wholly-owned subsidiary of Sequenom, Inc. , ...
... Office of Minority Health Urges "Know Your Risk and Help ... 17 Speaking at the Venous Disease Coalition (VDC) Annual Meeting ... the Department of Health and Human Services followed up on last ... African American population which is at significantly increased risk of Deep ...
... , DALLAS, Sept. 17 The Texas ... released its annual report on the prevalence, cost and quality ... includes information for key local markets across the state including ... Also included are state and national benchmarks that can help ...
... set by CDC need to be lowered, experts say , ... levels well below those considered safe are still at risk ... , Currently, the maximum safe blood level of lead is ... the U.S. Centers for Disease Control and Prevention in 1991. ...
... ... communications company. , ... Knoxville, TN (PRWeb) Sept. 17, 2009 -- Alan Weinstein was recently named chairman of ... innovative ways to leverage PerfectServe,s physician-contact network serving physician practices and hospitals nationwide. , ...
Cached Medicine News:Health News:Chemobrain -- the flip side of surviving cancer 2Health News:SEQUENOM Announces Launch of SensiGene Cystic Fibrosis Carrier Screening Test 2Health News:SEQUENOM Announces Launch of SensiGene Cystic Fibrosis Carrier Screening Test 3Health News:SEQUENOM Announces Launch of SensiGene Cystic Fibrosis Carrier Screening Test 4Health News:SEQUENOM Announces Launch of SensiGene Cystic Fibrosis Carrier Screening Test 5Health News:SEQUENOM Announces Launch of SensiGene Cystic Fibrosis Carrier Screening Test 6Health News:African Americans at Significantly Higher Risk of DVT or Blood Clots 2Health News:African Americans at Significantly Higher Risk of DVT or Blood Clots 3Health News:African Americans at Significantly Higher Risk of DVT or Blood Clots 4Health News:TBGH Report on Status of Diabetes in Texas Indicates Growing Severity of Problem and Higher Cost of Care Than National Average 2Health News:TBGH Report on Status of Diabetes in Texas Indicates Growing Severity of Problem and Higher Cost of Care Than National Average 3Health News:TBGH Report on Status of Diabetes in Texas Indicates Growing Severity of Problem and Higher Cost of Care Than National Average 4Health News:Even Small Amounts of Lead Harmful to Kids 2Health News:Even Small Amounts of Lead Harmful to Kids 3Health News:Alan Weinstein Named Chairman of PerfectServe Advisory Board 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: